Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

How often does tigecycline use result in severe diarrhea?

See the DrugPatentWatch profile for tigecycline

How often does tigecycline use result in severe diarrhea?

Tigecycline causes diarrhea in about 12% of patients, but severe cases are rare. Clinical reports show that most diarrhea cases remain mild to moderate and resolve without stopping treatment.

How common is C. diff infection after tigecycline?

Tigecycline disrupts gut bacteria and raises the risk of Clostridioides difficile (C. diff) infection, which can produce severe diarrhea. Reports vary from 0.3% to 2% across studies. The company’s own safety data recorded one case of pseudomembranous colitis in 2,400 patients.

What happens if severe diarrhea develops during tigecycline treatment?

Patients should stop taking the drug and seek medical care if they develop severe, persistent diarrhea during or after tigecycline use. Doctors usually test for C. diff toxin and may treat the infection with oral vancomycin or fidaxomicin.

Can other antibiotics replace tigecycline if diarrhea becomes a problem?

Yes. Alternatives such as linezolid, daptomycin, or meropenem provide coverage for similar bacteria without the same strong gut disruption. Doctors choose replacements based on susceptibility testing and patient-specific risks.

How does tigecycline’s safety profile compare with other tetracyclines?

Tigecycline belongs to the glycylcycline class and has a broader spectrum and larger disruption of normal gut flora than older tetracyclines. This explains why its diarrhea rate is higher than conditions like doxycycline, but similar or higher than some broad-spectrum antibiotics.

When does tigecycline’s patent expire?

Tigecycline’s composition-of-matter patent expired in 2016. The last remaining data exclusivity ended in 2017. Generics entered the U.S. market in 2018.



Other Questions About Tigecycline :

How does tigecycline's resistance to bacterial resistance differ from generic tetracyclines? How does tigecycline s patent extension influence access to affordable antibiotic alternatives? How is tigecycline resistance developed in bacteria? Does tigecycline s patent expiration lower side effects? Can tigecycline resistance in c difficile be overcome? How do excipients influence tigecycline's absorption and elimination? Does extended tigecycline usage change liver enzyme counts?